New metabolizable immunologic adjuvant for human use. 4. Development of highly purified influenza virus vaccine in adjuvant 65.
D000276:Adjuvants, Immunologic; D000818:Animals; D001681:Biological Assay; D006168:Guinea Pigs; D007252:Influenza Vaccines / Q000633:toxicity*; D051379:Mice
D000276:Adjuvants, Immunologic; D007252:Influenza Vaccines